Immunotoxins for the treatment of B-cell lymphomas.
作者信息
Ghetie M A, Ghetie V, Vitetta E S
机构信息
Cancer Immunobiology Center, University of Texas Southwestern Medical Center at Dallas 75235-8576, USA.
出版信息
Mol Med. 1997 Jul;3(7):420-7.
Abstract
摘要
相似文献
1
Immunotoxins for the treatment of B-cell lymphomas.
Mol Med. 1997 Jul;3(7):420-7.
2
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
Cancer Res. 1998 Aug 1;58(15):3320-30.
3
[New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
Dtsch Med Wochenschr. 1999 Jul 9;124(27):842-7. doi: 10.1055/s-2007-1024429.
4
Immunotoxins: From Design to Clinical Application.
Biomolecules. 2021 Nov 15;11(11):1696. doi: 10.3390/biom11111696.
5
6
Recent advances in cutaneous lymphomas.
J Dermatol Sci. 2007 Dec;48(3):157-67. doi: 10.1016/j.jdermsci.2007.09.001. Epub 2007 Oct 25.
7
Immunotoxins and toxin constructs in the treatment of leukemia and lymphoma.
Adv Pharmacol. 2004;51:209-28. doi: 10.1016/S1054-3589(04)51009-8.
8
Recombinant immunotoxins for treating cancer.
Int J Med Microbiol. 2004 Apr;293(7-8):577-82. doi: 10.1078/1438-4221-00302.
9
Technology evaluation: BL22, NCI.
Curr Opin Mol Ther. 2002 Feb;4(1):72-5.
10
Phase I immunotoxin trial in patients with B-cell lymphoma.
Cancer Res. 1991 Aug 1;51(15):4052-8.
引用本文的文献
1
Designing immunotoxins for cancer therapy.
Immunol Res. 2002;25(2):177-91. doi: 10.1385/IR:25:2:177.
2
Bacterial toxins: friends or foes?
Emerg Infect Dis. 1999 Mar-Apr;5(2):224-34. doi: 10.3201/eid0502.990206.
本文引用的文献
1
Lymphoma classification--the gap between biology and clinical management is closing.
Blood. 1996 Dec 1;88(11):4085-9.
2
Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies.
Bioconjug Chem. 1996 Sep-Oct;7(5):557-63. doi: 10.1021/bc960043y.
3
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma.
Blood. 1996 Aug 15;88(4):1188-97.
4
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration.
J Immunother Emphasis Tumor Immunol. 1995 Nov;18(4):231-41.
5
Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
Br J Cancer. 1995 Dec;72(6):1373-9. doi: 10.1038/bjc.1995.517.
6
7
Immunotoxins for the treatment of leukaemia.
Br J Haematol. 1993 Nov;85(3):435-8. doi: 10.1111/j.1365-2141.1993.tb03329.x.
8
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
Blood. 1994 Sep 1;84(5):1361-92.
9
Classification of lymphoid neoplasms.
Blood. 1994 Sep 1;84(5):1359-60.
10
Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
Cancer Res. 1993 Mar 15;53(6):1360-7.
Zotero 插件